report-image

Global Sexual Dysfunction Drugs Market Size By Segmentations, Top Key Players, Trend, Future Development & Forecast 2024-2035

  • PUBLISHED ON
  • 11/23/2022
  • NO OF PAGES
  • 270
  • CATEGORY
  • Healthcare & Life Sciences
The competitive landscape analysis of Sexual Dysfunction Drugs Market uncovers detailed company profiles, revenue shares, portfolio innovations, regional product footprint, key developmental strategies, pricing structure, target markets, and near-term plans of market leaders. This entire section helps readers gain an essence of what is driving competition and what would help them stand out to win new target markets.

Market estimates and forecast are backed by an extensive primary research, further complemented by on-point secondary research of Sexual Dysfunction Drugs Market. The research analysts have invested significant time and effort in gathering critical industry information from KIPs such as OEMs, top suppliers and distributors, and government bodies.

Market Segmentations:
The research report includes specific segments by region (country), by Company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2030. Understanding the segments helps in identifying the importance of different factors that aid the market growth.


Global Sexual Dysfunction Drugs Market: By Types
Oral Therapy
Intracavernosal Therapy
Hormonal Therapy
Transurethral Therapy

Global Sexual Dysfunction Drugs Market: By Applications
Male
Female

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

Global Sexual Dysfunction Drugs Market: Top Key Players
Pfizer
GlaxoSmithKline
Merck
Eli Lilly
AbbVie
Bayer
Teva Pharmaceutical Industries
Takeda
Apricus Biosciences
Emotional Brain
Ivix LLX
Leadiant Biosciences
NexMed
S1 Biopharma
Vietstar Biomedical Research


Global Sexual Dysfunction Drugs Market: Market Size Estimation
Both the top-down and bottom-up approaches were used to estimate and validate the size of the market and to estimate the size of various other dependent sub-markets of various marketspaces. The key players in the markets are identified through secondary research, and their market contributions in different applications across regions and globally were determined through primary and secondary research. This entire process included the study of the annual and financial reports of the top market players and extensive interviews for key insights with industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares, splits, and breakdowns were determined using secondary sources and verified through primary sources. All the possible parameters that affect the market covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analysed to arrive at the final quantitative and qualitative data. This data has been consolidated, and detailed inputs and analysis from Analytics Market Research added before being presented in this report.

Reasons to Purchase Sexual Dysfunction Drugs Market Report
• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come

Frequently Asked Questions
• What is the market size and growth projections?
• What is the market size and growth projection for each of the market segments and sub-segments across Countries & Regions?
• What are the top performing segments, and countries / regions of each of the markets?
• What is the market size and growth rate across key countries / regions?
• How big is the global & regional market in terms of revenue and volume?
• How far market will grow in forecast period in terms of revenue and volume?
• What factors will influence demand and supply trends across each markets during the forecast period?
• What are the technology trends shaping various markets?
• Which country / region has more opportunities?
• What is the COVID-19 impact on the market and how long will it take to recover?
• Who are the key competitors of market Players?
• What are the market share (%) of Key Players?
• What are the Merger & Acquisition, New Product Launch, Recent Development within each of the Markets?
• What are PEST analysis, Ecosystem Analysis, Porter's Five Forecast Analysis, Ansoff Matrix, and SWOT Analysis among other analyses for diverse markets?
Base Year: 2023
Historic Year: 2016-2022
Forecast: 2024-2035
1 Sexual Dysfunction Drugs Market Overview
1.1 Product Overview and Scope of Sexual Dysfunction Drugs
1.2 Sexual Dysfunction Drugs Segment by Type
1.2.1 Global Sexual Dysfunction Drugs Sales Growth Rate Comparison by Type (2022-2030)
1.2.2 Oral Therapy
1.2.3 Intracavernosal Therapy
1.2.4 Hormonal Therapy
1.2.5 Transurethral Therapy
1.3 Sexual Dysfunction Drugs Segment by Application
1.3.1 Sexual Dysfunction Drugs Sales Comparison by Application: (2022-2030)
1.3.2 Male
1.3.3 Female
1.4 Global Sexual Dysfunction Drugs Market Size Estimates and Forecasts
1.4.1 Global Sexual Dysfunction Drugs Revenue 2016-2030
1.4.2 Global Sexual Dysfunction Drugs Sales 2016-2030
1.4.3 Sexual Dysfunction Drugs Market Size by Region: 2016 Versus 2022 Versus 2030

2 Sexual Dysfunction Drugs Market Competition by Manufacturers
2.1 Global Sexual Dysfunction Drugs Sales Market Share by Manufacturers (2016-2021)
2.2 Global Sexual Dysfunction Drugs Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Sexual Dysfunction Drugs Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Sexual Dysfunction Drugs Manufacturing Sites, Area Served, Product Type
2.5 Sexual Dysfunction Drugs Market Competitive Situation and Trends
2.5.1 Sexual Dysfunction Drugs Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Sexual Dysfunction Drugs Players Market Share by Revenue
2.5.3 Global Sexual Dysfunction Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Sexual Dysfunction Drugs Retrospective Market Scenario by Region
3.1 Global Sexual Dysfunction Drugs Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Sexual Dysfunction Drugs Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Sexual Dysfunction Drugs Market Facts & Figures by Country
3.3.1 North America Sexual Dysfunction Drugs Sales by Country
3.3.2 North America Sexual Dysfunction Drugs Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Sexual Dysfunction Drugs Market Facts & Figures by Country
3.4.1 Europe Sexual Dysfunction Drugs Sales by Country
3.4.2 Europe Sexual Dysfunction Drugs Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Sexual Dysfunction Drugs Market Facts & Figures by Region
3.5.1 Asia Pacific Sexual Dysfunction Drugs Sales by Region
3.5.2 Asia Pacific Sexual Dysfunction Drugs Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Sexual Dysfunction Drugs Market Facts & Figures by Country
3.6.1 Latin America Sexual Dysfunction Drugs Sales by Country
3.6.2 Latin America Sexual Dysfunction Drugs Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Sexual Dysfunction Drugs Market Facts & Figures by Country
3.7.1 Middle East and Africa Sexual Dysfunction Drugs Sales by Country
3.7.2 Middle East and Africa Sexual Dysfunction Drugs Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Sexual Dysfunction Drugs Historic Market Analysis by Type
4.1 Global Sexual Dysfunction Drugs Sales Market Share by Type (2016-2021)
4.2 Global Sexual Dysfunction Drugs Revenue Market Share by Type (2016-2021)
4.3 Global Sexual Dysfunction Drugs Price by Type (2016-2021)

5 Global Sexual Dysfunction Drugs Historic Market Analysis by Application
5.1 Global Sexual Dysfunction Drugs Sales Market Share by Application (2016-2021)
5.2 Global Sexual Dysfunction Drugs Revenue Market Share by Application (2016-2021)
5.3 Global Sexual Dysfunction Drugs Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Corporation Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Sexual Dysfunction Drugs Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Pfizer Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 GlaxoSmithKline
6.2.1 GlaxoSmithKline Corporation Information
6.2.2 GlaxoSmithKline Description and Business Overview
6.2.3 GlaxoSmithKline Sexual Dysfunction Drugs Sales, Revenue and Gross Margin (2016-2021)
6.2.4 GlaxoSmithKline Product Portfolio
6.2.5 GlaxoSmithKline Recent Developments/Updates
6.3 Merck
6.3.1 Merck Corporation Information
6.3.2 Merck Description and Business Overview
6.3.3 Merck Sexual Dysfunction Drugs Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Merck Product Portfolio
6.3.5 Merck Recent Developments/Updates
6.4 Eli Lilly
6.4.1 Eli Lilly Corporation Information
6.4.2 Eli Lilly Description and Business Overview
6.4.3 Eli Lilly Sexual Dysfunction Drugs Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Eli Lilly Product Portfolio
6.4.5 Eli Lilly Recent Developments/Updates
6.5 AbbVie
6.5.1 AbbVie Corporation Information
6.5.2 AbbVie Description and Business Overview
6.5.3 AbbVie Sexual Dysfunction Drugs Sales, Revenue and Gross Margin (2016-2021)
6.5.4 AbbVie Product Portfolio
6.5.5 AbbVie Recent Developments/Updates
6.6 Bayer
6.6.1 Bayer Corporation Information
6.6.2 Bayer Description and Business Overview
6.6.3 Bayer Sexual Dysfunction Drugs Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Bayer Product Portfolio
6.6.5 Bayer Recent Developments/Updates
6.7 Teva Pharmaceutical Industries
6.6.1 Teva Pharmaceutical Industries Corporation Information
6.6.2 Teva Pharmaceutical Industries Description and Business Overview
6.6.3 Teva Pharmaceutical Industries Sexual Dysfunction Drugs Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Teva Pharmaceutical Industries Product Portfolio
6.7.5 Teva Pharmaceutical Industries Recent Developments/Updates
6.8 Takeda
6.8.1 Takeda Corporation Information
6.8.2 Takeda Description and Business Overview
6.8.3 Takeda Sexual Dysfunction Drugs Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Takeda Product Portfolio
6.8.5 Takeda Recent Developments/Updates
6.9 Apricus Biosciences
6.9.1 Apricus Biosciences Corporation Information
6.9.2 Apricus Biosciences Description and Business Overview
6.9.3 Apricus Biosciences Sexual Dysfunction Drugs Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Apricus Biosciences Product Portfolio
6.9.5 Apricus Biosciences Recent Developments/Updates
6.10 Emotional Brain
6.10.1 Emotional Brain Corporation Information
6.10.2 Emotional Brain Description and Business Overview
6.10.3 Emotional Brain Sexual Dysfunction Drugs Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Emotional Brain Product Portfolio
6.10.5 Emotional Brain Recent Developments/Updates
6.11 Ivix LLX
6.11.1 Ivix LLX Corporation Information
6.11.2 Ivix LLX Sexual Dysfunction Drugs Description and Business Overview
6.11.3 Ivix LLX Sexual Dysfunction Drugs Sales, Revenue and Gross Margin (2016-2021)
6.11.4 Ivix LLX Product Portfolio
6.11.5 Ivix LLX Recent Developments/Updates
6.12 Leadiant Biosciences
6.12.1 Leadiant Biosciences Corporation Information
6.12.2 Leadiant Biosciences Sexual Dysfunction Drugs Description and Business Overview
6.12.3 Leadiant Biosciences Sexual Dysfunction Drugs Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Leadiant Biosciences Product Portfolio
6.12.5 Leadiant Biosciences Recent Developments/Updates
6.13 NexMed
6.13.1 NexMed Corporation Information
6.13.2 NexMed Sexual Dysfunction Drugs Description and Business Overview
6.13.3 NexMed Sexual Dysfunction Drugs Sales, Revenue and Gross Margin (2016-2021)
6.13.4 NexMed Product Portfolio
6.13.5 NexMed Recent Developments/Updates
6.14 S1 Biopharma
6.14.1 S1 Biopharma Corporation Information
6.14.2 S1 Biopharma Sexual Dysfunction Drugs Description and Business Overview
6.14.3 S1 Biopharma Sexual Dysfunction Drugs Sales, Revenue and Gross Margin (2016-2021)
6.14.4 S1 Biopharma Product Portfolio
6.14.5 S1 Biopharma Recent Developments/Updates
6.15 Vietstar Biomedical Research
6.15.1 Vietstar Biomedical Research Corporation Information
6.15.2 Vietstar Biomedical Research Sexual Dysfunction Drugs Description and Business Overview
6.15.3 Vietstar Biomedical Research Sexual Dysfunction Drugs Sales, Revenue and Gross Margin (2016-2021)
6.15.4 Vietstar Biomedical Research Product Portfolio
6.15.5 Vietstar Biomedical Research Recent Developments/Updates

7 Sexual Dysfunction Drugs Manufacturing Cost Analysis
7.1 Sexual Dysfunction Drugs Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Sexual Dysfunction Drugs
7.4 Sexual Dysfunction Drugs Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Sexual Dysfunction Drugs Distributors List
8.3 Sexual Dysfunction Drugs Customers

9 Sexual Dysfunction Drugs Market Dynamics
9.1 Sexual Dysfunction Drugs Industry Trends
9.2 Sexual Dysfunction Drugs Growth Drivers
9.3 Sexual Dysfunction Drugs Market Challenges
9.4 Sexual Dysfunction Drugs Market Restraints

10 Global Market Forecast
10.1 Sexual Dysfunction Drugs Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Sexual Dysfunction Drugs by Type (2022-2030)
10.1.2 Global Forecasted Revenue of Sexual Dysfunction Drugs by Type (2022-2030)
10.2 Sexual Dysfunction Drugs Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Sexual Dysfunction Drugs by Application (2022-2030)
10.2.2 Global Forecasted Revenue of Sexual Dysfunction Drugs by Application (2022-2030)
10.3 Sexual Dysfunction Drugs Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Sexual Dysfunction Drugs by Region (2022-2030)
10.3.2 Global Forecasted Revenue of Sexual Dysfunction Drugs by Region (2022-2030)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

Quality Assurance Process

  1. We Market Research’s Quality Assurance program strives to deliver superior value to our clients.

We Market Research senior executive is assigned to each consulting engagement and works closely with the project team to deliver as per the clients expectations.

Market Research Process




We Market Research monitors 3 important attributes during the QA process- Cost, Schedule & Quality. We believe them as a critical benchmark in achieving a project’s success.

To mitigate risks that can impact project success, we deploy the follow project delivery best practices:
  • Project kickoff meeting with client
  • Conduct frequent client communications
  • Form project steering committee
  • Assign a senior SR executive as QA Executive
  • Conduct internal editorial & quality reviews of project deliverables
  • Certify project staff in SR methodologies & standards
  • Monitor client satisfaction
  • Monitor realized value post-project

Case Study- Automotive Sector

One of the key manufacturers of automotive had plans to invest in electric utility vehicles. The electric cars and associated markets being a of evolving nature, the automotive client approached Straits Research for a detailed insight on the market forecasts. The client specifically asked for competitive analysis, regulatory framework, regional prospects studied under the influence of drivers, challenges, opportunities, and pricing in terms of revenue and sales (million units).

Solution

The overall study was executed in three stages, intending to help the client meet its objective of precisely understanding the entire market before deciding on an investment. At first, secondary research was conducted considering political, economic, social, and technological parameters to get a gist of the various aspects of the market. This stage of the study concluded with the derivation of drivers, opportunities, and challenges. It also laid substantial emphasis on understanding and collecting data not only on a global scale but also on the regional and country levels. Data Extraction through Primary Research

The second stage involved primary research in which several market players and automotive parts suppliers were contacted to study their viewpoint concerning the development of their market and production capacity, clientele, and product line. This stage concluded in a brief understanding of the competitive ecosystem and also glanced through the strategies and pricing of the companies profiled.

Market Estimates and Forecast

In the final stage of the study, market forecasts for the electric utility were derived using multiple market engineering approaches. This data helped the client to get an overview of the market and accelerate the process of investment.

Case Study- ICT Sector

Business process outsourcing, being one of the lucrative markets from both supply- and demand- side, has appealed to various companies. One of the prominent corporations based out of Japan approached us with their requirements regarding the scope of the procurement outsourcing market for around 50 countries. Additionally, the client also sought key players operating in the market and their revenue breakdown in terms of region and application.


Business Solution

An exhaustive market study was conducted based on primary and secondary research that involved factors such as labor costs in various countries, skilled and technical labors, manufacturing scenario, and their respective contributions in the global GDP. A comparative study of the market was conducted from both supply- and demand side, with the supply-side comprising of notable companies, such as GEP, Accenture, and others, that provide these services. On the other hand, large manufacturing companies from them demand-side were considered that opt for these services.


Conclusion

The report aided the client in understanding the market trends, including country-level business scenarios, consumer behavior, and trends in 50 countries. The report also provided financial insights of crucial players and detailed market estimations and forecasts till 2028.

Sample Request Customized Requirement Speak to Analyst Check Discount
CHOOSE LICENSE TYPE
QLOUD
Pricing

Select a license type that suits your business needs

Single User Access

US $3950

Only Three Thousand Nine Hundred Fifty US dollar

Buy Now
  • 1 User access
  • 15% Additional Free Customization
  • Free Unlimited post-sale support
  • 100% Service Guarantee until achievement of ROI
Multi User Cost

US $4950

Only Four Thousand Nine Hundred Fifty US dollar

Buy Now
  • 5 Users access
  • 25% Additional Free Customization
  • Access Report summaries for Free
  • Guaranteed service
  • Dedicated Account Manager
  • Discount of 20% on next purchase
  • Get personalized market brief from Lead Author
  • Printing of Report permitted
  • Discount of 20% on next purchase
  • 100% Service Guarantee until achievement of ROI
Enterprise User Cost

US $5950

Only Five Thousand Nine Hundred Fifty US dollar

Buy Now
  • Unlimited User Access
  • 30% Additional Free Customization
  • Exclusive Previews to latest or upcoming reports
  • Discount of 30% on next purchase
  • 100% Service Guarantee until achievement of ROI